BIRC6 and neuroblastoma: This is consistent with our recent discovery that Survivin is a target for autophagosomal removal in neuroblastoma [38, 51] and our results are in line with data on another IAP, BIRC6/BRUCE, which is also degraded via autophagosomal removal [25].